Literature DB >> 16462022

Andrographolide inhibits the production of TNF-alpha and interleukin-12 in lipopolysaccharide-stimulated macrophages: role of mitogen-activated protein kinases.

Lin-Hua Qin1, Ling Kong, Guo-Jun Shi, Zheng-Tao Wang, Bao-Xue Ge.   

Abstract

Andrographolide has been reported to possess a variety of pharmacological activities. In this study, we have investigated the effect of andrographolide on the production of TNF-alpha and IL-12 (Interleukin-12) in murine peritoneal macrophages. Andrographolide decreased TNF-alpha, IL-12a and IL-12b at mRNA level, and reduced the production of TNF-alpha and IL-12p70 proteins in a concentration-dependent manner. Furthermore, we have found that addition of andrographolide inhibited the activation of ERK1/2 MAP kinase, but not that of JNK, p38 or NF-kappaB. These results suggested that andrographolide inhibit LPS-induced production of TNF-alpha via suppression of the ERK1/2 signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16462022     DOI: 10.1248/bpb.29.220

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  13 in total

1.  Protective effect of andrographolide against concanavalin A-induced liver injury.

Authors:  Guojun Shi; Zhijian Zhang; Rong Zhang; Xiaofang Zhang; Yan Lu; Jian Yang; Di Zhang; Zhiguo Zhang; Xiaoying Li; Guang Ning
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-09-24       Impact factor: 3.000

2.  Anti-Inflammatory Effects of Hypophyllanthin and Niranthin Through Downregulation of NF-κB/MAPKs/PI3K-Akt Signaling Pathways.

Authors:  Hemavathy Harikrishnan; Ibrahim Jantan; Md Areeful Haque; Endang Kumolosasi
Journal:  Inflammation       Date:  2018-06       Impact factor: 4.092

3.  Annexin-1 Mimetic Peptide Ac2-26 Suppresses Inflammatory Mediators in LPS-Induced Astrocytes and Ameliorates Pain Hypersensitivity in a Rat Model of Inflammatory Pain.

Authors:  Zhenzhao Luo; Hui Wang; Shiqiang Fang; Li Li; Xing Li; Jing Shi; Man Zhu; Zheqiong Tan; Zhongxin Lu
Journal:  Cell Mol Neurobiol       Date:  2019-11-13       Impact factor: 5.046

4.  Neuroprotective effects of andrographolide in a rat model of permanent cerebral ischaemia.

Authors:  Su Jing Chan; W S Fred Wong; Peter T H Wong; Jin-Song Bian
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

5.  Andrographolide inhibits oral squamous cell carcinogenesis through NF-κB inactivation.

Authors:  L-J Wang; X Zhou; W Wang; F Tang; C-L Qi; X Yang; S Wu; Y-Q Lin; J-T Wang; J-G Geng
Journal:  J Dent Res       Date:  2011-08-12       Impact factor: 6.116

6.  Immunomodulatory activity of andrographolide on macrophage activation and specific antibody response.

Authors:  Wei Wang; Jing Wang; Sheng-fu Dong; Chun-hong Liu; Paola Italiani; Shu-hui Sun; Jing Xu; Diana Boraschi; Shi-ping Ma; Di Qu
Journal:  Acta Pharmacol Sin       Date:  2010-02       Impact factor: 6.150

7.  Isolation and identification of bioactive compounds in Andrographis paniculata (Chuanxinlian).

Authors:  Wen-Wan Chao; Bi-Fong Lin
Journal:  Chin Med       Date:  2010-05-13       Impact factor: 5.455

8.  Efficacy of an Andrographis paniculata composition for the relief of rheumatoid arthritis symptoms: a prospective randomized placebo-controlled trial.

Authors:  R A Burgos; J L Hancke; J C Bertoglio; V Aguirre; S Arriagada; M Calvo; D D Cáceres
Journal:  Clin Rheumatol       Date:  2009-04-29       Impact factor: 2.980

9.  Inhibitory effects of neoandrographolide on nitric oxide and prostaglandin E2 production in LPS-stimulated murine macrophage.

Authors:  Jun Liu; Zheng-Tao Wang; Li-Li Ji; Bao-Xue Ge
Journal:  Mol Cell Biochem       Date:  2006-11-16       Impact factor: 3.842

10.  Experimental and Clinical Pharmacology of Andrographis paniculata and Its Major Bioactive Phytoconstituent Andrographolide.

Authors:  Thanasekaran Jayakumar; Cheng-Ying Hsieh; Jie-Jen Lee; Joen-Rong Sheu
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-24       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.